UroGen Pharma Ltd.

NasdaqGM:URGN Stock Report

Market Cap: US$526.6m

UroGen Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:URGN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Mar 24SellUS$168,600Mark SchoenbergIndividual12,000US$14.05
01 Feb 24SellUS$78,790Jason SmithIndividual4,993US$15.78
01 Feb 24SellUS$59,790Mark SchoenbergIndividual3,789US$15.78

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of URGN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,328,0195.46%
Hedge Funds7,523,08817.7%
Institutions32,750,07076.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 36.7%.


Top Shareholders

Top 25 shareholders own 82.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.97%
RTW Investments, LP
3,787,347US$47.3m6.47%0.61%
8.85%
Adage Capital Management, L.P.
3,735,741US$46.6m13.2%0.08%
5.92%
BlackRock, Inc.
2,497,943US$31.2m13.9%no data
5.46%
Menora Mivtachim Pensions & Gemel Ltd.
2,303,031US$28.7m0%0.14%
5.14%
Morgan Stanley, Investment Banking and Brokerage Investments
2,170,527US$27.1m18.8%no data
4.26%
Cowen Inc,Private Banking and Investment Banking Investments
1,796,589US$22.4m-14.4%0.59%
3.73%
Monograph Capital Partners
1,572,327US$19.6m0%no data
3.67%
Cormorant Asset Management, LP
1,550,000US$19.3m-6.06%0.87%
3.6%
Point72 Asset Management, L.P.
1,520,007US$19.0m-39.1%0.04%
3.55%
Millennium Management LLC
1,499,201US$18.7m29.1%0.01%
3.52%
Pontifax Venture Capital
1,485,168US$18.5m0%6.17%
3.29%
UBS Asset Management AG
1,386,847US$17.3m4.13%no data
3.24%
Moshe Arkin
1,369,315US$17.1m0%no data
2.84%
Credit Suisse Asset Management (Switzerland) Ltd.
1,200,000US$15.0m0%0.02%
2.29%
Jefferies Financial Group Inc.,Asset Management Arm
965,000US$12.0m0%0.55%
2.14%
Silverarc Capital Management, LLC
901,129US$11.2m-18.2%2.46%
1.82%
State Street Global Advisors, Inc.
769,583US$9.6m5.9%no data
1.8%
Great Point Partners, LLC
758,786US$9.5m-73.9%3.23%
1.63%
Migdal Mutual Funds Ltd.
686,472US$8.6m0%0.07%
1.32%
Medical Strategy GmbH, Asset Management Arm
555,223US$6.9m0%0.39%
1.17%
Wildcat Capital Management, LLC
495,606US$6.2m0%2.61%
1.1%
Harel Insurance Investments and Finances Services Ltd, Asset Management Arm
463,267US$5.8m-0.06%0.06%
1.09%
Dafna Capital Management, LLC
458,915US$5.7m-2.15%1.36%
1.08%
Geode Capital Management, LLC
455,637US$5.7m8.13%no data
0.97%
Arie Belldegrun
408,693US$5.1m0%no data